Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
Susanna Hilda Hutajulu,1 Johan Kurnianda,1 I Bing Tan,2,3 Jaap M Middeldorp4 1Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada/Dr Sardjito General Hospital, Yogyakarta, Indonesia; 2Department of Ear, Nose and Throat, The Netherlands Cancer Institute/Antoni van Le...
Saved in:
Main Authors: | Hutajulu SH (Author), Kurnianda J (Author), Tan IB (Author), Middeldorp JM (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epstein-Barr DNA in advanced pediatric nasopharyngeal cancer
by: Marlinda Adham, et al.
Published: (2021) -
Infection by Epstein-Barr virus in Fes (Morocco). Prevalence and predictors of positivity in nasopharyngeal cancer
by: Mehdi El-, et al.
Published: (2018) -
Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom
by: Ashvin Kuri, et al.
Published: (2020) -
Epstein-Barr Virus-associated Gastric Carcinoma
by: Bong Eun Lee
Published: (2021) -
The burden of Epstein-Barr virus infections in children⁎
by: Henry H. BalfourJr
Published: (2022)